Millennium Management
DTIL icon

Millennium Management’s Precision BioSciences DTIL Stock Holding History

Millennium Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,000
Closed -$250K – 6036
2020
Q4 		$250K Buy
+1,000
New +$245K ﹤0.01% 4676

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management's DTIL Position: Q1 2026 in Review

Millennium Management opened a new position in Precision BioSciences (DTIL) in Q1 2026: 27,684 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #5253 among its holdings. This is a return to the name: Millennium Management previously reported a position in DTIL as recently as Q1 2025.

Millennium Management first reported a position in DTIL in Q1 2019 and has held it in 20 quarters since. The position peaked at $6.43M in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Millennium Management held 27,684 shares of Precision BioSciences worth $152K as of Q1 2026.
  • Precision BioSciences was a new Millennium Management position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5253 holding.
  • Millennium Management first reported a position in Precision BioSciences in Q1 2019 and has held it in 20 quarters since.
  • Millennium Management's Precision BioSciences position peaked at $6.43M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.